Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Active-Controlled Phase 3 Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Conditions
Interventions
ABP 959
Eculizumab
Locations
24
United States
Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
Fakultní Nemocnice Brno
Brno, Jihormoravsky KRAJ, Czechia
Fakultní Nemocnice Olomouc
Olomouc, Czechia
Fakultní Nemocnice Ostrava
Ostrava-Poruba, Czechia
Keski-Suomen keskussairaala Jyväskylä
Jyväskylä, Finland
Päijät-Häme Central Hospital
Lahti, Finland
Start Date
January 22, 2019
Primary Completion Date
July 12, 2022
Completion Date
July 12, 2022
Last Updated
May 23, 2023
NCT03520647
NCT04645199
NCT07152288
NCT06411626
NCT06298955
NCT05389449
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions